top of page
ARIYA BIO
Our Mission
We use genome engineering to develop a cure for the most common deadly monogenic disorders worldwide, the Hemoglobinopathies
At Ariya Bio we focus on hereditary blood diseases and employ cutting-edge genome engineering tools to develop next-generation cell and gene therapies.
Our diverse team of researchers is working every day to bring cutting-edge therapeutics to patients around the world
Our Programs
"We are working towards a cure for a disease that really needs one"
Mandy Boontanrart
bottom of page